Biopharma developing HLA-based immunotherapies for cancer and autoimmune disease.
| Date | Round | Amount |
|---|---|---|
| Sep 2024 | Series C ImmunOs Therapeutics, a Swiss immunotherapy biopharma, raised an $11M Series C led by existing investors including Gimv and Pfizer Ventures. | $11M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.